CPHI | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 7%

Liquidity 37%

Performance 0%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

2.13%

1 Month

-18.91%

3 Months

-67.72%

6 Months

-68.43%

1 Year

144.22%

2 Year

63.57%

Key data

Stock price

$0.56

P/E Ratio

0.00

DAY RANGE

$0.56 - $0.57

EPS

-$0.57

52 WEEK RANGE

$0.12 - $2.60

52 WEEK CHANGE

$144.22

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

5.022 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-29-2025

BETA

1.35

PUBLIC FLOAT

AVERAGE 10 VOLUME

$19,415

AVERAGE 30 VOLUME

$20,812

Company detail

CEO: Zhi L. Li
Region: US
Website: chinapharmaholdings.com
Employees: 250
IPO year: 2002

Issue type: Common Stock
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain.

CPHI - CHINA PHARMA HOLDINGS, INC.